Genomic Valley Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

3.05

3.05

3.05

3.05

3.05

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

0.47

-0.18

1.43

1.99

1.71

Loan funds

Secured loans

0.61

-

1.55

1.48

1.48

Unsecured loans

-

-

-

-

-

Total

4.14

2.88

6.04

6.53

6.24

Uses of funds

Fixed assets

Gross block

0.48

2.57

6.60

5.02

4.70

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

0.48

0.82

0.74

0.55

0.39

Net block

-

1.75

5.86

4.47

4.31

Capital work-in-progress

-

-

0.49

0.49

0.49

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

4.42

2.04

1.27

3.05

2.38

Less : current liabilities & provisions

0.28

0.92

1.58

1.48

0.94

Total net current assets

4.13

1.12

-0.31

1.57

1.44

Miscellaneous expenses not written

-

-

-

-

-

Total

4.14

2.88

6.04

6.53

6.24

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

30.55

30.55

30.55

30.55

30.55